close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Gasthalter & Co. on behalf of CytoDyn Inc. shareholders

Group of CytoDyn Stockholders Comments on Delaware Court Decision
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockholders Releases White Paper Regarding Company’s Extremely Unfavorable Borrowing Practices
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockholders Shares Strategic Plan to Obtain Cancer Therapy Approval for Leronlimab
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockholders Announces Federal Court Dismisses Litigation Brought by Company
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Bruce Patterson, M.D., Director Candidate for CytoDyn Board, Presents at International COVID Summit
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockolders Responds to Misleading Company News Release
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockholders Warns Stockholders of Board’s Continued Value Destruction and Failures
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockholders Files Lawsuit to Force Company to Allow Stockholders to Vote for Alternative Director Nominees
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of CytoDyn Stockholders Responds to Highly Misleading Company Release
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Group of Cytodyn Stockholders Nominates Five Highly Qualified Director Candidates to Replace Board Responsible for Mismanagement and Value Destruction
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Tickers CYDY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today